{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:32:57Z","timestamp":1794018777707,"version":"4.8.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T00:00:00Z","timestamp":1761436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T00:00:00Z","timestamp":1761436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10096-025-05324-0","type":"journal-article","created":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T05:09:48Z","timestamp":1761455388000},"page":"383-393","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical characteristics and risk factors of mortality in patients with candidemia: a four-year retrospective study"],"prefix":"10.1007","volume":"45","author":[{"given":"Shuang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,26]]},"reference":[{"key":"5324_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2021.101210","author":"M Vannini","year":"2022","unstructured":"Vannini M, Emery S, Lieutier-Colas F, Legueult K, Mondain V, Retur N, Gastaud L, Pomares C, Hasseine L (2022) Epidemiology of candidemia in NICE area, france: a five-year study of antifungal susceptibility and mortality. J Med Mycol. https:\/\/doi.org\/10.1016\/j.mycmed.2021.101210","journal-title":"J Med Mycol"},{"issue":"10","key":"5324_CR2","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.cmi.2019.04.024","volume":"25","author":"P Koehler","year":"2019","unstructured":"Koehler P, Stecher M, Cornely OA, Koehler D, Vehreschild MJGT, Bohlius J, Wisplinghoff H, Vehreschild JJ (2019) Morbidity and mortality of candidaemia in europe: an epidemiologic meta-analysis. Clin Microbiol Infect 25(10):1200\u20131212. https:\/\/doi.org\/10.1016\/j.cmi.2019.04.024","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"5324_CR3","doi-asserted-by":"publisher","first-page":"P9","DOI":"10.1164\/rccm.2005P9","volume":"200","author":"E Kotthoff-Burrell","year":"2019","unstructured":"Kotthoff-Burrell E (2019) Candidemia (blood infection) and other candida infections. Am J Respir Crit Care Med 200(5):P9\u2013P10. https:\/\/doi.org\/10.1164\/rccm.2005P9","journal-title":"Am J Respir Crit Care Med"},{"key":"5324_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-10128-2","author":"C Zhang","year":"2024","unstructured":"Zhang C, Wu S, Chen X, Yang H, Feng W, Yuan T, Wang Y (2024) Clinical manifestations and treatment of candidemia caused by different Candida species: a retrospective study. BMC Infect Dis. https:\/\/doi.org\/10.1186\/s12879-024-10128-2","journal-title":"BMC Infect Dis"},{"issue":"3","key":"5324_CR5","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.ccm.2017.04.010","volume":"38","author":"O Epelbaum","year":"2017","unstructured":"Epelbaum O, Chasan R (2017) Candidemia in the intensive care unit. Clin Chest Med 38(3):493\u2013509. https:\/\/doi.org\/10.1016\/j.ccm.2017.04.010","journal-title":"Clin Chest Med"},{"issue":"11","key":"5324_CR6","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1080\/14737159.2019.1660644","volume":"19","author":"TE Sweeney","year":"2019","unstructured":"Sweeney TE, Liesenfeld O, May L (2019) Diagnosis of bacterial sepsis: why are tests for bacteremia not sufficient? Expert Rev Mol Diagn 19(11):959\u2013962. https:\/\/doi.org\/10.1080\/14737159.2019.1660644","journal-title":"Expert Rev Mol Diagn"},{"issue":"2","key":"5324_CR7","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1093\/cid\/ciae234","volume":"79","author":"AM Peri","year":"2024","unstructured":"Peri AM, Chatfield MD, Ling W, Furuya-Kanamori L, Harris PNA, Paterson DL (2024) Rapid diagnostic tests and antimicrobial stewardship programs for the management of bloodstream infection: what is their relative contribution to improving clinical outcomes? A systematic review and network meta-analysis. Clin Infect Dis 79(2):502\u2013515. https:\/\/doi.org\/10.1093\/cid\/ciae234","journal-title":"Clin Infect Dis"},{"key":"5324_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2024.107176","author":"Y Dai","year":"2024","unstructured":"Dai Y, Zhu X, Chang W, Lu H, Nie Z, Wu Y, Yao H, Chen Y, Xiao Y, Chu X (2024) Clinical and economic evaluation of blood culture whole process optimisation in critically ill adult patients with positive blood cultures. Int J Antimicrob Agents. https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107176","journal-title":"Int J Antimicrob Agents"},{"key":"5324_CR9","doi-asserted-by":"publisher","unstructured":"Zeng X, Lloyd KM, Hamdy RF, Shapiro CA, Fisher MA, Lin J, Liu BM, Banerjee R (2025) Identification and characterization of an invasive, hyper-aerotolerant Campylobacter jejunistrain causing bacteremia in a pediatric leukemia patient. ASM Case Rep 1(3). https:\/\/doi.org\/10.1128\/asmcr.00060-24","DOI":"10.1128\/asmcr.00060-24"},{"key":"5324_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11060788","author":"J Hou","year":"2022","unstructured":"Hou J, Deng J, Liu Y, Zhang W, Wu S, Liao Q, Ma Y, Kang M (2022) Epidemiology, clinical characteristics, risk factors, and outcomes of candidemia in a large tertiary teaching hospital in Western China: a retrospective 5-year study from 2016 to 2020. Antibiotics. https:\/\/doi.org\/10.3390\/antibiotics11060788","journal-title":"Antibiotics"},{"issue":"1","key":"5324_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-020-00798-3","volume":"9","author":"Z Zeng","year":"2020","unstructured":"Zeng Z, Ding Y, Tian G, Yang K, Deng J, Li G, Liu J (2020) A seven-year surveillance study of the epidemiology, antifungal susceptibility, risk factors and mortality of candidaemia among paediatric and adult inpatients in a tertiary teaching hospital in China. Antimicrob Resist Infect Control 9(1):133. https:\/\/doi.org\/10.1186\/s13756-020-00798-3","journal-title":"Antimicrob Resist Infect Control"},{"key":"5324_CR12","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.2147\/IDR.S477815","volume":"17","author":"K Li","year":"2024","unstructured":"Li K, Yang X, Li L, Zhi L (2024) Candidaemia: A 9-Year retrospective analysis of epidemiology and antimicrobial susceptibility in tertiary care hospitals in Western China. Infect Drug Resist Volume 17:3891\u20133900. https:\/\/doi.org\/10.2147\/IDR.S477815","journal-title":"Infect Drug Resist Volume"},{"key":"5324_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-10908-4","author":"T Liu","year":"2025","unstructured":"Liu T, Sun S, Zhu X, Wu H, Sun Z, Peng S (2025) Epidemiology, clinical characteristics, and outcome in candidemia: a retrospective five-year analysis from two tertiary general hospitals. BMC Infect Dis. https:\/\/doi.org\/10.1186\/s12879-025-10908-4","journal-title":"BMC Infect Dis"},{"key":"5324_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/jof10100707","author":"S Meneghello","year":"2024","unstructured":"Meneghello S, Bernab\u00e8 G, Di Pietra G, Di Sopra S, Del Vecchio C, Cattelan AM, Castagliuolo I, Brun P (2024) Prevalence, species distribution and resistance of candidemia in pediatric and adult patients in a Northeast Italy university hospital. J Fungi. https:\/\/doi.org\/10.3390\/jof10100707","journal-title":"J Fungi"},{"issue":"1","key":"5324_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-020-00755-8","volume":"10","author":"M Schroeder","year":"2020","unstructured":"Schroeder M, Weber T, Denker T, Winterland S, Wichmann D, Rohde H, Ozga A-K, Fischer M, Kluge S (2020) Epidemiology, clinical characteristics, and outcome of candidemia in critically ill patients in Germany: a single-center retrospective 10-year analysis. Ann Intensive Care 10(1):142. https:\/\/doi.org\/10.1186\/s13613-020-00755-8","journal-title":"Ann Intensive Care"},{"key":"5324_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11060771","author":"C Routsi","year":"2022","unstructured":"Routsi C, Meletiadis J, Charitidou E, Gkoufa A, Kokkoris S, Karageorgiou S, Giannopoulos C, Koulenti D, Andrikogiannopoulos P, Perivolioti E, Argyropoulou A, Vasileiadis I, Vrioni G, Paramythiotou E (2022) Epidemiology of candidemia and fluconazole resistance in an ICU before and during the COVID-19 pandemic era. Antibiotics. https:\/\/doi.org\/10.3390\/antibiotics11060771","journal-title":"Antibiotics"},{"key":"5324_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/jof7070577","author":"S Boonsilp","year":"2021","unstructured":"Boonsilp S, Homkaew A, Phumisantiphong U, Nutalai D, Wongsuk T (2021) Species distribution, antifungal susceptibility, and molecular epidemiology of Candida species causing candidemia in a tertiary care hospital in Bangkok, Thailand. J Fungi. https:\/\/doi.org\/10.3390\/jof7070577","journal-title":"J Fungi"},{"key":"5324_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08241-9","author":"Y Li","year":"2023","unstructured":"Li Y, Gu C, Yang Y, Ding Y, Ye C, Tang M, Liu J, Zeng Z (2023) Epidemiology, antifungal susceptibility, risk factors, and mortality of persistent candidemia in adult patients in China: a 6-year multicenter retrospective study. BMC Infect Dis. https:\/\/doi.org\/10.1186\/s12879-023-08241-9","journal-title":"BMC Infect Dis"},{"issue":"Supplement2","key":"5324_CR19","doi-asserted-by":"publisher","first-page":"S139","DOI":"10.1093\/infdis\/jiz573","volume":"221","author":"Y-C Xu","year":"2020","unstructured":"Xu Y-C, Wang H, Kang W, Duan S-M, Zhang J-J, Yang Y, Zhang G, Huang J-J, Yu S-Y, Li Y, Zhou M-L, Cheng J-W, Hou X, Fan X, Kong H-S, Yan L, Xu X-L, Kong F, Chen SCA, Xiao M (2020) Distribution and antifungal susceptibility of Candida species causing candidemia in china: an update from the CHIF-NET study. J Infect Dis 221(Supplement2):S139\u2013S147. https:\/\/doi.org\/10.1093\/infdis\/jiz573","journal-title":"J Infect Dis"},{"key":"5324_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-021-00441-y","author":"Y-J Zheng","year":"2021","unstructured":"Zheng Y-J, Xie T, Wu L, Liu X-Y, Zhu L, Chen Y, Mao E-Q, Han L-Z, Chen E-Z, Yang Z-T (2021) Epidemiology, species distribution, and outcome of nosocomial Candida spp. bloodstream infection in Shanghai: an 11-year retrospective analysis in a tertiary care hospital. Ann Clin Microbiol Antimicrob. https:\/\/doi.org\/10.1186\/s12941-021-00441-y","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"5324_CR21","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2022.2153086","author":"Y Ning","year":"2022","unstructured":"Ning Y, Xiao M, Perlin DS, Zhao Y, Lu M, Li Y, Luo Z, Dai R, Li S, Xu J, Liu L, He H, Liu Y, Li F, Guo Y, Chen Z, Xu Y, Sun T, Zhang L (2022) Decreased echinocandin susceptibility in Candida parapsilosis causing candidemia and emergence of a pan-echinocandin resistant case in China. Emerg Microbes Infect. https:\/\/doi.org\/10.1080\/22221751.2022.2153086","journal-title":"Emerg Microbes Infect"},{"key":"5324_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/jof10070481","author":"S Dolatabadi","year":"2024","unstructured":"Dolatabadi S, Najafzadeh MJ, Raeisabadi A, Zarrinfar H, Jalali M, Spruijtenburg B, Meijer EFJ, Meis JF, Lass-Fl\u00f6rl C, de Groot T (2024) Epidemiology of candidemia in Mashhad, Northeast Iran: a prospective multicenter study (2019\u20132021). J Fungi. https:\/\/doi.org\/10.3390\/jof10070481","journal-title":"J Fungi"},{"key":"5324_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00934","author":"O Tulyaprawat","year":"2020","unstructured":"Tulyaprawat O, Pharkjaksu S, Chongtrakool P, Ngamskulrungroj P (2020) An association of an eBURST group with triazole resistance of Candida tropicalis blood isolates. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2020.00934","journal-title":"Front Microbiol"},{"issue":"1","key":"5324_CR24","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1080\/21505594.2022.2123325","volume":"13","author":"H Bilal","year":"2022","unstructured":"Bilal H, Shafiq M, Hou B, Islam R, Khan MN, Khan RU, Zeng Y (2022) Distribution and antifungal susceptibility pattern ofcandidaspecies from Mainland china: a systematic analysis. Virulence 13(1):1573\u20131589. https:\/\/doi.org\/10.1080\/21505594.2022.2123325","journal-title":"Virulence"},{"issue":"suppl1","key":"5324_CR25","doi-asserted-by":"publisher","first-page":"i4","DOI":"10.1093\/jac\/dkx444","volume":"73","author":"F Lamoth","year":"2018","unstructured":"Lamoth F, Lockhart SR, Berkow EL, Calandra T (2018) Changes in the epidemiological landscape of invasive candidiasis. J Antimicrob Chemother 73(suppl1):i4\u2013i13. https:\/\/doi.org\/10.1093\/jac\/dkx444","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"5324_CR26","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1093\/jac\/dkw422","volume":"72","author":"B Chapman","year":"2016","unstructured":"Chapman B, Slavin M, Marriott D, Halliday C, Kidd S, Arthur I, Bak N, Heath CH, Kennedy K, Morrissey CO, Sorrell TC, van Hal S, Keighley C, Goeman E, Underwood N, Hajkowicz K, Hofmeyr A, Leung M, Macesic N, Botes J, Blyth C, Cooley L, George CR, Kalukottege P, Kesson A, McMullan B, Baird R, Robson J, Korman TM, Pendle S, Weeks K, Chen S (2016) Changing epidemiology of candidaemia in Australia. J Antimicrob Chemother 72(4):1103\u20131108. https:\/\/doi.org\/10.1093\/jac\/dkw422","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"5324_CR27","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cmi.2019.03.028","volume":"25","author":"KE Pristov","year":"2019","unstructured":"Pristov KE, Ghannoum MA (2019) Resistance of Candida to azoles and echinocandins worldwide. Clin Microbiol Infect 25(7):792\u2013798. https:\/\/doi.org\/10.1016\/j.cmi.2019.03.028","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"5324_CR28","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1080\/09546634.2021.1942421","volume":"33","author":"AK Gupta","year":"2021","unstructured":"Gupta AK, Venkataraman M (2021) Antifungal resistance in superficial mycoses. J Dermatolog Treat 33(4):1888\u20131895. https:\/\/doi.org\/10.1080\/09546634.2021.1942421","journal-title":"J Dermatolog Treat"},{"key":"5324_CR29","doi-asserted-by":"publisher","unstructured":"Whaley SG, Berkow EL, Rybak JM, Nishimoto AT, Barker KS, Rogers PD (2017) Azole antifungal resistance in Candida albicans and emerging Non-albicans Candida species. Front Microbiol 7. https:\/\/doi.org\/10.3389\/fmicb.2016.02173","DOI":"10.3389\/fmicb.2016.02173"},{"issue":"12","key":"5324_CR30","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1016\/S1473-3099(17)30316-X","volume":"17","author":"DS Perlin","year":"2017","unstructured":"Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A (2017) The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis 17(12):e383\u2013e392. https:\/\/doi.org\/10.1016\/S1473-3099(17)30316-X","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"5324_CR31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1021\/acsinfecdis.4c00477","volume":"11","author":"F Askari","year":"2024","unstructured":"Askari F, Kaur R (2024) Candida glabrata: a tale of stealth and endurance. ACS Infect Dis 11(1):4\u201320. https:\/\/doi.org\/10.1021\/acsinfecdis.4c00477","journal-title":"ACS Infect Dis"},{"key":"5324_CR32","doi-asserted-by":"publisher","unstructured":"Sumana SU MN (2023) Retrospective analysis on distribution and antifungal susceptibility profile of Candida in clinical samples: a study from Southern India. Front Public Health 11. https:\/\/doi.org\/10.3389\/fpubh.2023.1160841","DOI":"10.3389\/fpubh.2023.1160841"},{"issue":"1","key":"5324_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-2766-1","volume":"24","author":"J Poissy","year":"2020","unstructured":"Poissy J, Damonti L, Bignon A, Khanna N, Von Kietzell M, Boggian K, Neofytos D, Vuotto F, Coiteux V, Artru F, Zimmerli S, Pagani J-L, Calandra T, Sendid B, Poulain D, van Delden C, Lamoth F, Marchetti O, Bochud P-Y (2020) Risk factors for candidemia: a prospective matched case-control study. Crit Care 24(1):109. https:\/\/doi.org\/10.1186\/s13054-020-2766-1","journal-title":"Crit Care"},{"issue":"9","key":"5324_CR34","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s10096-018-3304-9","volume":"37","author":"X Jia","year":"2018","unstructured":"Jia X, Li C, Cao J, Wu X, Zhang L (2018) Clinical characteristics and predictors of mortality in patients with candidemia: a six-year retrospective study. Eur J Clin Microbiol Infect Dis 37(9):1717\u20131724. https:\/\/doi.org\/10.1007\/s10096-018-3304-9","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"5324_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac078","author":"A Arastehfar","year":"2022","unstructured":"Arastehfar A, \u00dcnal N, Ho\u015fbul T, Alper \u00d6zarslan M, Sultan Karakoyun A, Polat F, Fuentes D, G\u00fcmral R, Turun\u00e7 T, Daneshnia F, Perlin DS, Lass-Fl\u00f6rl C, Gabald\u00f3n T, Ilkit M, Nguyen MH (2022) Candidemia among coronavirus disease 2019 patients in Turkey admitted to intensive care units: a retrospective multicenter study. Open Forum Infect Dis. https:\/\/doi.org\/10.1093\/ofid\/ofac078","journal-title":"Open Forum Infect Dis"},{"key":"5324_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.744502","author":"L Zhang","year":"2021","unstructured":"Zhang L, Xiao M, Arastehfar A, Ilkit M, Zou J, Deng Y, Xu Y, Liao W, Zhao J, Fang W, Pan W (2021) Investigation of the emerging nosocomial Wickerhamomyces anomalus infections at a Chinese tertiary teaching hospital and a systemic review: clinical manifestations, risk factors, treatment, outcomes, and anti-fungal susceptibility. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2021.744502","journal-title":"Front Microbiol"},{"key":"5324_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e28033","author":"S Kazancioglu","year":"2024","unstructured":"Kazancioglu S, Bodur H, Mumcuoglu I, Bastug A, Ozbay BO, Aydos O, Dinc B (2024) Candidemia in critically ill COVID-19 patients: risk factors and impact on mortality. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28033","journal-title":"Heliyon"},{"issue":"8","key":"5324_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens14080806","volume":"14","author":"JP Cabrera-Guerrero","year":"2025","unstructured":"Cabrera-Guerrero JP, Garc\u00eda-Salazar E, Hernandez Silva G, Chinney Herrera A, Mart\u00ednez-Herrera E, Pinto-Almaz\u00e1n R, Fr\u00edas-De-Le\u00f3n MG, Castro-Fuentes CA (2025) Candidemia: an update on epidemiology, risk factors, diagnosis, susceptibility, and treatment. Pathogens 14(8):806. https:\/\/doi.org\/10.3390\/pathogens14080806","journal-title":"Pathogens"},{"issue":"6","key":"5324_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/jof9060642","volume":"9","author":"F Pallotta","year":"2023","unstructured":"Pallotta F, Brescini L, Ianovitz A, Luchetti I, Franca L, Canovari B, Cerutti E, Barchiesi F (2023) The clinical characteristics of bloodstream infections due to Candida spp. in patients hospitalized in intensive care units during the SARS-CoV-2 pandemic: the results of a multicenter study. J Fungi 9(6):642. https:\/\/doi.org\/10.3390\/jof9060642","journal-title":"J Fungi"},{"key":"5324_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-022-00538-y","author":"L Zhong","year":"2022","unstructured":"Zhong L, Dong Z, Liu F, Li H, Tang K, Zheng C, Wang L, Zhang K, Cai J, Zhou H, Cui W, Gao Y, Zhang G (2022) Incidence, clinical characteristics, risk factors and outcomes of patients with mixed Candida\/bacterial bloodstream infections: a retrospective study. Ann Clin Microbiol Antimicrob. https:\/\/doi.org\/10.1186\/s12941-022-00538-y","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"5324_CR41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ejim.2017.03.005","volume":"41","author":"M Falcone","year":"2017","unstructured":"Falcone M, Tiseo G, Tascini C, Russo A, Sozio E, Raponi G, Rosin C, Pignatelli P, Carfagna P, Farcomeni A, Luzzati R, Violi F, Menichetti F, Venditti M (2017) Assessment of risk factors for candidemia in non-neutropenic patients hospitalized in internal medicine wards: a multicenter study. Eur J Intern Med 41:33\u201338. https:\/\/doi.org\/10.1016\/j.ejim.2017.03.005","journal-title":"Eur J Intern Med"},{"key":"5324_CR42","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2147\/DDDT.S501664","volume":"Volume 19","author":"X Li","year":"2025","unstructured":"Li X, Yu B, Li H, Liu Z, Fu X, Jiao P, Wang L (2025) Drug clues for the treatment of fungal catheter-related bloodstream infection with antifungal lock therapy. Drug Des Devel Ther Volume 19:683\u2013701. https:\/\/doi.org\/10.2147\/DDDT.S501664","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"5324_CR43","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/mmy\/myy008","volume":"57","author":"RW Hooper","year":"2019","unstructured":"Hooper RW, Ashcraft DS, Pankey GA (2019) In vitro synergy with fluconazole plus doxycycline or tigecycline against clinical Candida glabrata isolates. Med Mycol 57(1):122\u2013126. https:\/\/doi.org\/10.1093\/mmy\/myy008","journal-title":"Med Mycol"},{"issue":"4","key":"5324_CR44","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10096-021-04394-0","volume":"41","author":"M Kutlu","year":"2022","unstructured":"Kutlu M, Say\u0131n-Kutlu S, Alp-\u00c7avu\u015f S, \u00d6zt\u00fcrk \u015eB, Ta\u015fbakan M, \u00d6zhak B, Kaya O, Kutsoylu OE, \u015eenol-Akar \u015e, Turhan \u00d6, Mermut G, Ertu\u011frul B, Pullukcu H, \u00c7etin \u00c7B, Avkan-O\u011fuz V, Yapar N, Ye\u015fim-Metin D, Ergin \u00c7 (2022) Mortality-associated factors of candidemia: a multi-center prospective cohort in Turkey. Eur J Clin Microbiol Infect Dis 41(4):597\u2013607. https:\/\/doi.org\/10.1007\/s10096-021-04394-0","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"5324_CR45","doi-asserted-by":"publisher","unstructured":"Bakhtiar A, Haider Kazmi SJ, Asghar MS, Khurshaidi MN, Mazhar S, Khan NA, Ahmed N, Yasmin F, Yaseen R, Hassan M (2021) Accuracy of procalcitonin levels for diagnosis of Culture-Positive sepsis in critically ill trauma patients: A retrospective analysis.\u00a0Cureus\u00a0https:\/\/doi.org\/10.7759\/cureus.12988.","DOI":"10.7759\/cureus.12988"},{"key":"5324_CR46","doi-asserted-by":"publisher","DOI":"10.1093\/burnst\/tkad031","author":"J Yoon","year":"2023","unstructured":"Yoon J, Kym D, Hur J, Park J, Kim M, Cho YS, Chun W, Yoon D (2023) The clinical differentiation of blood culture-positive and -negative sepsis in burn patients: a retrospective cohort study. Burns Trauma. https:\/\/doi.org\/10.1093\/burnst\/tkad031","journal-title":"Burns Trauma"},{"key":"5324_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2024.156803","author":"X Fang","year":"2025","unstructured":"Fang X, Su C, Luo Y, Pan K, Lin J, Song Y, Huang Y, Hu X, Shen Z (2025) Risk factors associated with short-term mortality in patients with candidemia and the predictive value of serum cytokine level. Cytokine. https:\/\/doi.org\/10.1016\/j.cyto.2024.156803","journal-title":"Cytokine"},{"key":"5324_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10101349","author":"SJ Taj-Aldeen","year":"2021","unstructured":"Taj-Aldeen SJ, Mir FA, Sivaraman SK, AbdulWahab A (2021) Serum cytokine profile in patients with candidemia versus bacteremia. Pathogens. https:\/\/doi.org\/10.3390\/pathogens10101349","journal-title":"Pathogens"},{"key":"5324_CR49","doi-asserted-by":"publisher","unstructured":"Lazzeri C, R\u00edos-Toro J-J, M\u00e1rquez-Coello M, Garc\u00eda-\u00c1lvarez J-M, Mart\u00edn-Aspas A, Rivera-Fern\u00e1ndez R, S\u00e1ez de Benito A, Gir\u00f3n-Gonz\u00e1lez J-A (2017) Soluble membrane receptors, Interleukin 6, procalcitonin and C reactive protein as prognostic markers in patients with severe sepsis and septic shock. PLoS ONE 12(4). https:\/\/doi.org\/10.1371\/journal.pone.0175254","DOI":"10.1371\/journal.pone.0175254"},{"issue":"4","key":"5324_CR50","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3343\/alm.2023.43.4.381","volume":"43","author":"YW Lee","year":"2023","unstructured":"Lee YW, Lim SY, Jin S, Park HJ, Sung H, Kim M-N, Bae S, Jung J, Kim MJ, Kim S-H, Lee S-O, Choi S-H, Kim YS, Chong YP (2023) Clinical sensitivity of the (1\u20133)-\u03b2-D-glucan test for predicting candidemia. Ann Lab Med 43(4):381\u2013385. https:\/\/doi.org\/10.3343\/alm.2023.43.4.381","journal-title":"Ann Lab Med"},{"key":"5324_CR51","doi-asserted-by":"publisher","unstructured":"Corcione S, Chasseur L, Lupia T, Shbaklo N, Scabini S, Filippini C, Mornese Pinna S, Morra di Celle S, Cavallo R, De Rosa FG (2022) The diagnostic relevance of \u03b2-D-Glucan for candidemia within internal medicine wards. Diagnostics 12(9). https:\/\/doi.org\/10.3390\/diagnostics12092124","DOI":"10.3390\/diagnostics12092124"},{"key":"5324_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/jof11020091","author":"E Novy","year":"2025","unstructured":"Novy E, Esposito M, Debourgogne A, Roger C (2025) Reevaluating the value of (1,3)-\u03b2-D-glucan for the diagnosis of intra-abdominal candidiasis in critically ill patients: current evidence and future directions. J Fungi. https:\/\/doi.org\/10.3390\/jof11020091","journal-title":"J Fungi"},{"issue":"3","key":"5324_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/jof8030308","volume":"8","author":"R Dobi\u00e1\u0161","year":"2022","unstructured":"Dobi\u00e1\u0161 R, K\u00e1\u0148ov\u00e1 M, Petejov\u00e1 N, Pisti \u0160K, Bocek R, Krej\u010d\u00ed E, Stru\u017ekov\u00e1 H, Cachov\u00e1 M, Tom\u00e1\u0161kov\u00e1 H, Hamal P, Havl\u00ed\u010dek V, Ra\u0161ka M (2022) Combined use of presepsin and (1,3)-\u03b2-D-glucan as biomarkers for diagnosing Candida sepsis and monitoring the effectiveness of treatment in critically ill patients. J Fungi 8(3):308. https:\/\/doi.org\/10.3390\/jof8030308","journal-title":"J Fungi"},{"issue":"3","key":"5324_CR54","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/myc.13224","volume":"64","author":"P Esteves","year":"2020","unstructured":"Esteves P, Lopes Lima S, Salles de Azevedo Melo A, Maria Beir\u00e3o E, Nucci M, Colombo AL (2020) (1,3)-\u03b2\u2010D\u2010glucan is able to predict therapeutic failure of patients with candidemia and not only mortality. Mycoses 64(3):264\u2013271. https:\/\/doi.org\/10.1111\/myc.13224","journal-title":"Mycoses"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05324-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-025-05324-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05324-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:44:29Z","timestamp":1773409469000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-025-05324-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,26]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["5324"],"URL":"https:\/\/doi.org\/10.1007\/s10096-025-05324-0","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,26]]},"assertion":[{"value":"30 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Third People\u2019s Hospital of Chengdu, the Afffliated Hospital of Southwest Jiaotong University Institutional Review Board, and the Biomedical Ethics Committee, Chengdu, China (2025-S-187). The ethics committee waived the need for written informed consent provided by participants due to the retrospective nature of the study. Because all patient data were analyzed in anonymity, no dditional informed consent was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}